Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
- PMID: 11160128
- PMCID: PMC199185
- DOI: 10.1172/JCI11998
Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
Figures
Comment on
-
Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.J Clin Invest. 2001 Jan;107(2):R1-7. doi: 10.1172/JCI11642. J Clin Invest. 2001. PMID: 11160141 Free PMC article.
References
-
- Coral-Vazquez R, et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 1999;98:465–474. - PubMed
-
- Towbin JA, et al. X-linked dilated cardiomyopathy (XLCM): molecular genetic evidence of linkage to the Duchenne muscular dystrophy gene at the Xp21 locus. Circulation. 1993;87:1854–1865. - PubMed
-
- Li D, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation. 1999;100:461–464. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
